home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  November 20, 2018
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Z] 551 active entries

Gero

Kosmonavta Volkova 6a-1205
Moscow, 125319
Russia

Phone: 1608696
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.

Description:

 

  • GERO (ex Quantum Pharmaceuticals) is a drug discovery company designing first in class small molecule therapeutics using proprietary, industry leading molecular modeling and systems biology technologies.

  • Since being established in 2004, the company has developed a portfolio of preclinical, first in class small molecules against high-interest targets in cancer metabolism, diabetes, and neuroprotection.

  • Recently, our focus has turned to developing new medicines to combat the aging process and extend healthy human lifespans. We have developed new insights into aging biology, primarily around the stability and stress resistance of certain gene regulatory networks 1.

  • Our research has revealed new druggable targets which we believe will translate into innovative medicines to delay a number of age related diseases, including human frailty and mortality itself . By combining our powerful molecular modelling capabilities with our insights into the biology of important new drug targets, we are developing a portfolio of new medicines which delay human mortality while maintaining a high quality of life.


Selected Categories:
Product Company   Service Company
Biopharma
- Research
Biotech
- Research
Consulting
- Software
Contract
- Research
- Services

Last update of this entry: August 06, 2015

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.